Skip to main content
. 2017 Sep 12;17:646. doi: 10.1186/s12885-017-3641-6

Fig. 1.

Fig. 1

Duration of exposure and RECIST evaluation (FAS, N = 54). Footnote: ESCC esophageal squamous cell carcinoma, PD progressive disease, PR partial response, Q2W once every two weeks, QW once weekly, RECIST Response Evaluation Criteria In Solid Tumors, SCCHN squamous cell carcinoma of the head and neck, SD stable disease, UNK unknown